Probiotics for the prevention of pediatric antibiotic-associated diarrhea (Q24235039)

object named as

Gordon H Guyatt

0 references

Bradley C Johnston

object named as

Bradley C Johnston

0 references

author name string

Joshua Z Goldenberg

0 references

Xin Sun

Cochrane Database of Systematic Reviews

0 references

language of work or name

English

0 references

publication date

9 November 2011

0 references

published in

0 references

issue

0 references

page(s)

CD004827

0 references

cites work

Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

Does eating yogurt prevent antibiotic-associated diarrhoea? A placebo-controlled randomised controlled trial in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

The probiotic effect of Saccharomyces boulardii in a pediatric age group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

Randomized, double-blind, placebo-controlled trial: effect of lactobacillus GG supplementation on Helicobacter pylori eradication rates and side effects during treatment in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

Bifidobacterium longum PL03, Lactobacillus rhamnosus KL53A, and Lactobacillus plantarum PL02 in the prevention of antibiotic-associated diarrhea in children: a randomized controlled pilot trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

Effect of a milk formula with prebiotics on the intestinal microbiota of infants after an antibiotic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

The effects of probiotics on PPI-triple therapy for Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

The effect of a multispecies probiotic on the intestinal microbiota and bowel movements in healthy volunteers taking the antibiotic amoxycillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

Lactobacillus reuteri therapy to reduce side-effects during anti-Helicobacter pylori treatment in children: a randomized placebo controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

Prevention of antibiotic-associated diarrhea in children by Clostridium butyricum MIYAIRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

Clinical safety of Lactobacillus casei shirota as a probiotic in critically ill children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

Effects of a specially designed fermented milk product containing probiotic Lactobacillus casei DN-114 001 and the eradication of H. pylori in children: a prospective randomized double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

LOST to follow-up Information in Trials (LOST-IT): a protocol on the potential impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

Antibiotic-Associated Pseudomembranous Colitis Due to Toxin-Producing Clostridia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

Effect of a fermented milk combining Lactobacillus acidophilus Cl1285 and Lactobacillus casei in the prevention of antibiotic-associated diarrhea: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

Operating characteristics of a rank correlation test for publication bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

Safety of probiotics that contain lactobacilli or bifidobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

Standardising outcomes for clinical trials and systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

Dietary modulation of the human colonic microbiota: updating the concept of prebiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

What is "quality of evidence" and why is it important to clinicians?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

Safety of probiotics: comparison of two popular strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

Risk of bias versus quality assessment of randomised controlled trials: cross sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

What is meant by intention to treat analysis? Survey of published randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

Better reporting of harms in randomized trials: an extension of the CONSORT statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

Interpretation of tests of heterogeneity and bias in meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

Probiotics for pediatric antibiotic-associated diarrhea: a meta-analysis of randomized placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

Probiotics for the prevention of pediatric antibiotic-associated diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

Measurement issues in trials of pediatric acute diarrheal diseases: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

Role of Lactobacillus in the prevention of antibiotic-associated diarrhea: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

Lactobacillus sepsis associated with probiotic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

The case of the misleading funnel plot

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

The use of probiotics in gastrointestinal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

Epidemiology, risk factors and treatments for antibiotic-associated diarrhea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

Antibiotic-associated diarrhea: epidemiology, trends and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

Systematic review and meta-analysis of Saccharomyces boulardii in adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

Antimicrobial-associated risk factors for Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

Demonstration of safety of probiotics -- a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

Meta-analysis: non-pathogenic yeast Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

Probiotics in the prevention of antibiotic-associated diarrhea in children: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

Safety of probiotics in patients receiving nutritional support: a systematic review of case reports, randomized controlled trials, and nonrandomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

A Randomized Formula Controlled Trial of Bifidobacterium lactis and Streptococcus thermophilus for Prevention of Antibiotic-Associated Diarrhea in Infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

Spontaneously fermented millet product as a natural probiotic treatment for diarrhoea in young children: An intervention study in Northern Ghana

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

A randomized clinical trial measuring the influence of kefir on antibiotic-associated diarrhea: the measuring the influence of Kefir (MILK) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

7 January 2021

A dose dependent impact of prebiotic galactooligosaccharides on the intestinal microbiota of healthy adults

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

7 January 2021

Probiotics and immune response

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

7 January 2021

Modulation of the intestinal ecosystem by probiotics and lactulose in children during treatment with ceftriaxone

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

7 January 2021

Probiotics plus antibiotics: regulating our bacterial environment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

7 January 2021

Are live saccharomyces yeasts harmful to patients?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

7 January 2021

Can Saccharomyces boulardii prevent antibiotic-associated diarrhea in children?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

7 January 2021

Prevention of antibiotic-associated diarrhoea by a fermented probiotic milk drink

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

7 January 2021

Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

7 January 2021

Probiotics, prebiotics, and synbiotics--approaching a definition

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

7 January 2021

Proceedings of the International Symposium on Probiotics and Prebiotics. Kiel, Germany, June 11-12, 1998

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

7 January 2021

Lactobacilli and bacteremia in southern Finland, 1989-1992

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

7 January 2021

Incidence and risk factors of oral antibiotic-associated diarrhea in an outpatient pediatric population

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

7 January 2021

Lack of relationship of Clostridium difficile to antibiotic-associated diarrhea in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

7 January 2021

Meningitis caused by Bifidobacterium in an infant

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

7 January 2021

Probiotic administration and the incidence of nosocomial infection in pediatric intensive care: a randomized placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

7 January 2021

Saccharomyces boulardii and antibiotic-associated diarrhoea in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

7 January 2021

Clinical trial: effectiveness of Lactobacillus rhamnosus (strains E/N, Oxy and Pen) in the prevention of antibiotic-associated diarrhoea in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

7 January 2021

Lactobacillus endocarditis caused by a probiotic organism

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

7 January 2021

Benefits of oral supplementation with and without synbiotics in young children with acute bacterial infections

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

7 January 2021

A double-blind, placebo-controlled study of the efficacy of Lactinex in the prophylaxis of amoxicillin-induced diarrhea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

7 January 2021

Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004827.PUB3

7 January 2021